SOLIGENIX, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SOLIGENIX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-12-31 was $0.00.
- SOLIGENIX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $0.00.
- SOLIGENIX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $154.84K.
- SOLIGENIX, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $99.42K.
- SOLIGENIX, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $254.26K, a 7607.06% increase from fiscal 2023.
- SOLIGENIX, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $3.30K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $254.26K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | |
| 2024-06-30 | $154.84K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $99.42K 10-Q · filed 2025-05-09 | |
| 2023-12-31 | $3.30K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |